Critical Role of TBX20 in Cardiomyocyte Maturation during Direct Cardiac Reprogramming
TBX20 在直接心脏重编程过程中心肌细胞成熟中的关键作用
基本信息
- 批准号:10455734
- 负责人:
- 金额:$ 37.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-25 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AffectBiological AssayCalciumCardiacCardiac MyocytesCell MaturationCellsChromatinCicatrixComputer AnalysisDataDermalDeveloped CountriesDevelopmentFamilyFibroblastsFutureGene ActivationGene Expression ProfilingGenerationsGenesGeneticGenetic TranscriptionGenomicsHeartHeart failureHistonesHumanImageIn SituIn VitroInjuryIntercellular JunctionsIon ChannelLeftMembraneMolecularMorbidity - disease rateMusMyocardial InfarctionMyocardial IschemiaMyofibrilsNatural regenerationNeonatalOpticsPatientsPerformancePlayProcessRegulationReportingResearchResidual stateRoleRouteSarcomeresStructureSystemTechnologyTestingTherapeuticTimeTissuesTransactivationTransmission Electron Microscopybasecardiac repairclinical applicationclinical translationcofactorepigenomicsgenetic signaturein vivoinducible gene expressioninjuredinsightloss of functionmortalitymultiple omicsnoveloverexpressionpenis foreskinprogramsprotein expressionsingle-cell RNA sequencingstem cell differentiationtranscription factortranscriptometranscriptomicstreatment strategytumorigenesisvoltage
项目摘要
SUMMARY
Direct cardiac reprogramming to generated induced cardiomyocytes (iCMs) from fibroblasts has emerged as a
promising therapeutic strategy for the treatment of heart failure, which is still the leading cause of mortality and
morbidity in the developed country. While much is known regarding iCMs generated from mouse cells, the
adaptation of direct cardiac reprogramming to human cells is hurdled with low efficiency and poor quality
because of intrinsic differences between species. We recently reported the single cell transcriptomic analysis
during human cardiac reprogramming and discovered that the insufficient generation of iCMs is associated
with underdeveloped gene programs, such as ion channel and cell junction, suggesting that additional
reprogramming factors regulating function of cardiomyocytes might be required. In this research program, we
hypothesis that a novel reprogramming factor TBX20 plays an essential role to generate cardiomyocyte identity
by establishing gene programs associated with cardiomyocyte function. In support of our hypothesis, our
preliminary data have shown that TBX20 is largely under-expressed in human iCMs. While forced expression
of TBX20 significantly enhanced reprogramming efficiency accompanied with activation of gene programs
associated with cardiomyocyte function. To test the hypothesis, we propose to 1) further determine the impact
of TBX20 on direct human cardiac reprogramming and 2) determine how TBX20 functions as an essential
reprogramming factor during this process. The main objective of this proposal is to identify the critical role of
TBX20 on regeneration of cardiomyocytes during direct cardiac reprogramming. The completion of this
proposal will not only provide mechanistic insight into how cardiomyocyte identity can be regenerated by direct
cardiac reprogramming but also enable us to generate functional-reliable cardiomyocytes directly from human
non-myocytes for potential heart repair.
总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yang Zhou其他文献
Yang Zhou的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yang Zhou', 18)}}的其他基金
Targeting CHI3L and its receptors in Hermansky-Pudlak Syndrome-associated lung disease
靶向 CHI3L 及其受体治疗赫曼斯基-普德拉克综合征相关肺部疾病
- 批准号:
10850273 - 财政年份:2023
- 资助金额:
$ 37.13万 - 项目类别:
Targeting CHI3L1 and its receptors in Hermansky-Pudlak Syndrome-associated lung disease
靶向 CHI3L1 及其受体治疗赫曼斯基-普德拉克综合征相关肺部疾病
- 批准号:
10554375 - 财政年份:2020
- 资助金额:
$ 37.13万 - 项目类别:
Targeting CHI3L1 and its receptors in Hermansky-Pudlak Syndrome-associated lung disease
靶向 CHI3L1 及其受体治疗赫曼斯基-普德拉克综合征相关肺部疾病
- 批准号:
10355479 - 财政年份:2020
- 资助金额:
$ 37.13万 - 项目类别:
Targeting CHI3L1 and its receptors in Hermansky-Pudlak Syndrome-associated lung disease
靶向 CHI3L1 及其受体治疗赫曼斯基-普德拉克综合征相关肺部疾病
- 批准号:
9887633 - 财政年份:2020
- 资助金额:
$ 37.13万 - 项目类别:
Critical Role of TBX20 in Cardiomyocyte Maturation during Direct Cardiac Reprogramming
TBX20 在直接心脏重编程过程中心肌细胞成熟中的关键作用
- 批准号:
10033650 - 财政年份:2020
- 资助金额:
$ 37.13万 - 项目类别:
Critical Role of TBX20 in Cardiomyocyte Maturation during Direct Cardiac Reprogramming
TBX20 在直接心脏重编程过程中心肌细胞成熟中的关键作用
- 批准号:
10662347 - 财政年份:2020
- 资助金额:
$ 37.13万 - 项目类别:
Critical Role of TBX20 in Cardiomyocyte Maturation during Direct Cardiac Reprogramming
TBX20 在直接心脏重编程过程中心肌细胞成熟中的关键作用
- 批准号:
10245150 - 财政年份:2020
- 资助金额:
$ 37.13万 - 项目类别:
CHI3L1 and its Receptors in Vascular Remodeling and Pulmonary Hypertension Associated with Pulmonary Fibrosis
CHI3L1 及其受体在与肺纤维化相关的血管重塑和肺动脉高压中的作用
- 批准号:
10437834 - 财政年份:2013
- 资助金额:
$ 37.13万 - 项目类别:
CHI3L1 and its Receptors in Vascular Remodeling and Pulmonary Hypertension Associated with Pulmonary Fibrosis
CHI3L1 及其受体在与肺纤维化相关的血管重塑和肺动脉高压中的作用
- 批准号:
10200080 - 财政年份:2013
- 资助金额:
$ 37.13万 - 项目类别:
CHI3L1 and its Receptors in Vascular Remodeling and Pulmonary Hypertension Associated with Pulmonary Fibrosis
CHI3L1 及其受体在与肺纤维化相关的血管重塑和肺动脉高压中的作用
- 批准号:
9573405 - 财政年份:
- 资助金额:
$ 37.13万 - 项目类别:
相似海外基金
Establishment of a new biological assay using Hydra nematocyst deployment
利用水螅刺丝囊部署建立新的生物测定方法
- 批准号:
520728-2017 - 财政年份:2017
- 资助金额:
$ 37.13万 - 项目类别:
University Undergraduate Student Research Awards
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
10368760 - 财政年份:2017
- 资助金额:
$ 37.13万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
10669539 - 财政年份:2017
- 资助金额:
$ 37.13万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
9570142 - 财政年份:2017
- 资助金额:
$ 37.13万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
9915803 - 财政年份:2017
- 资助金额:
$ 37.13万 - 项目类别:
COVID-19 Supplemental work: POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER).
COVID-19 补充工作:用于确定组织特异性吸收电离辐射剂量的护理点生物测定(生物剂量计)。
- 批准号:
10259999 - 财政年份:2017
- 资助金额:
$ 37.13万 - 项目类别:
Drug discovery based on a new biological assay system using Yeast knock-out strain collection
基于使用酵母敲除菌株收集的新生物测定系统的药物发现
- 批准号:
21580130 - 财政年份:2009
- 资助金额:
$ 37.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Machine learning for automatic gene annotation using high-throughput biological assay data
使用高通量生物测定数据进行自动基因注释的机器学习
- 批准号:
300985-2004 - 财政年份:2005
- 资助金额:
$ 37.13万 - 项目类别:
Postdoctoral Fellowships
Machine learning for automatic gene annotation using high-throughput biological assay data
使用高通量生物测定数据进行自动基因注释的机器学习
- 批准号:
300985-2004 - 财政年份:2004
- 资助金额:
$ 37.13万 - 项目类别:
Postdoctoral Fellowships














{{item.name}}会员




